We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk (TIERRA)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00874185
First Posted: April 2, 2009
Last Update Posted: February 13, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Pfizer
April 1, 2009
April 2, 2009
February 13, 2013
December 2007
May 2008   (Final data collection date for primary outcome measure)
  • EDITS [ Time Frame: 6 months ]
  • SEAR [ Time Frame: 6 months ]
Same as current
Complete list of historical versions of study NCT00874185 on ClinicalTrials.gov Archive Site
Medication prescribed [ Time Frame: 6 months ]
Same as current
Not Provided
Not Provided
 
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk
Satisfaction With Treatment In Patients With Erectile Dysfunction And Cardiovascular Risk And/Or Previous Cardiovascular Event.
Evaluate satisfaction in people treated with IPDE5 inhibitors over time
12 first patients that are eligible
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
People with cv risk
Erectile Dysfunction
Not Provided
Questionnaire
filling in questionnaires
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
720
May 2008
May 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • CV risk factors
  • Male above 18

Exclusion Criteria:

  • Non-informed consent
Sexes Eligible for Study: Male
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT00874185
A1481256
A1481256
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
February 2013